Follow
Andrew Gasparrini
Andrew Gasparrini
Empress Therapeutics
Verified email at empresstx.com
Title
Cited by
Cited by
Year
Next-generation approaches to understand and combat the antibiotic resistome
TS Crofts, AJ Gasparrini, G Dantas
Nature Reviews Microbiology 15 (7), 422-434, 2017
5362017
Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome
AJ Gasparrini, B Wang, X Sun, EA Kennedy, A Hernandez-Leyva, ...
Nature microbiology 4 (12), 2285-2297, 2019
2262019
Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance
AJ Gasparrini, JL Markley, H Kumar, B Wang, L Fang, S Irum, CT Symister, ...
Communications biology 3 (1), 241, 2020
1272020
Antibiotic perturbation of the preterm infant gut microbiome and resistome
AJ Gasparrini, TS Crofts, MK Gibson, PI Tarr, BB Warner, G Dantas
Gut microbes 7 (5), 443-449, 2016
1222016
Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut
N Crook, A Ferreiro, AJ Gasparrini, MW Pesesky, MK Gibson, B Wang, ...
Cell host & microbe 25 (4), 499-512. e8, 2019
1102019
Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes
J Park, AJ Gasparrini, MR Reck, CT Symister, JL Elliott, JP Vogel, ...
Nature chemical biology 13 (7), 730-736, 2017
1072017
Multiscale evolutionary dynamics of host-associated microbiomes
A Ferreiro, N Crook, AJ Gasparrini, G Dantas
Cell 172 (6), 1216-1227, 2018
1042018
Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes
B Adu‐Oppong, AJ Gasparrini, G Dantas
Annals of the New York Academy of Sciences 1388 (1), 42-58, 2017
512017
Maternal activation of the EGFR prevents translocation of gut-residing pathogenic Escherichia coli in a model of late-onset neonatal sepsis
KA Knoop, PE Coughlin, AN Floyd, IM Ndao, C Hall-Moore, N Shaikh, ...
Proceedings of the National Academy of Sciences 117 (14), 7941-7949, 2020
412020
Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes
JL Markley, L Fang, AJ Gasparrini, CT Symister, H Kumar, NH Tolia, ...
ACS infectious diseases 5 (4), 618-633, 2019
292019
Inhibition and diagnostics of emerging tetracycline resistance enzymes
N Tolia, G Dantas, T Wencewicz, J Park, A Gasparrini, K Forsberg, ...
US Patent 10,273,468, 2019
12019
Physiologically acceptable compositions containing microorganisms or microbial products
DG Cole, J Park, SY Yang, AJ Gasparrini
US Patent App. 18/009,395, 2023
2023
Semisynthetic analogues of anhydrotetracycline as potential inhibitors of tetracycline destructase enzymes
J Markley, L Fang, A Gasparrini, C Symister, H Kumar, G Dantas, N Tolia, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018
2018
Mechanistic characterization of resistome and microbiome dynamics across diverse microbial habitats
AJ Gasparrini
Washington University in St. Louis, 2018
2018
Identifying Potential Drivers of Differential DNA Methylation Patterns in Breast Cancer Cells
A Fennoy, J Fong, J Andrews, A Gasparrini, J Edwards
The FASEB Journal 29, LB143, 2015
2015
Metagenomic signatures of early life hospitalization and antibiotic treatment in the infant gut microbiota and resistome persist long after discharge
AJ Gasparrini, B Wang, X Sun, EA Kennedy, A Hernandez-Leyva, ...
The system can't perform the operation now. Try again later.
Articles 1–16